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Background: Adult patients with cystic fibrosis (CF) have resting abnormal large artery haemodynamics. Here, we obtain further insight in
patients with CF by evaluating haemodynamic response to physiological stress.
Methods: Thirty-six stable CF patients mean (SD) age 28.9 (9.0)years and 25 controls matched for age, gender and body mass index were studied.
Central haemodynamic parameters; including augmentation index (AIx) and wasted left ventricular pressure energy (ΔEW) were determined pre,
during and post light intensity cycle ergometry.
Results: During exercise, despite a similar heart rate and blood pressure, patients had comparatively greater ΔEW (P=0.03) and trend towards
greater AIx (P=0.07) than controls. Exercise ΔEW was greatest in patients with CF related diabetes (n=11). In all subjects, exercise ΔEW was
related to age (r=0.54, Pb0.001) and FEV1% predicted (r=−0.32, P=0.01).
Conclusions: Adults with CF have an abnormal haemodynamic response to exercise. This finding has deleterious implications for myocardial
performance.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cardiovascular; Inflammation; Exercise; Arterial stiffness; Diabetes mellitus1. Introduction
Improved longevity in cystic fibrosis (CF) has prompted
increased focus on extra-pulmonary complications and co-
morbidities [1]. In this respect, it is now apparent that adult
patients with mild to moderate severity CF have evidence of
abnormalities in their systemic large arterial circulation [2].☆ Data from this manuscript were presented at the British Thoracic Society
Winter Meeting, London, 3rd December 2009 and Artery Research 9,
Cambridge, 11th September 2009.
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doi:10.1016/j.jcf.2010.12.001Specifically that the augmentation index (AIx), a composite
vascular parameter of arterial stiffness and global arterial wave
reflection, is elevated in this population under resting
conditions.
It is recognized however that greater insight into the health
and function of the cardiovascular system can be obtained by
evaluating its response to physiological stress, such as exercise
[3]. During exercise, the cardiovascular system responds to
increased metabolic and oxygen demands by a complex
combination of alterations in heart rate (HR), cardiac contrac-
tility and functional properties of the large arteries [4]. A key
component of this response is vasodilatation of the large
arteries, which acts to optimize coupling between the left
ventricle (LV) and systemic vascular system and lessen cardiacd by Elsevier B.V. All rights reserved.
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to increased myocardial work, decreased coronary perfusion
and impact upon exercise capacity [6]. Moreover it is
recognized that the pattern of exercise haemodynamic response
relates to structural myocardial abnormalities [7] and is
predictive of adverse cardiovascular outcome [8].
Haemodynamic response to exercise has traditionally been
assessed by evaluating peripheral blood pressure (BP) measured
at the brachial artery. However, owing to the phenomenon of
pulse pressure amplification (PPA), this has been found to relate
poorly to central BP [9]; especially during exercise when
differences between central to peripheral BP are magnified
[10,11]. Thus the physiological stress placed on the cardiovas-
cular system, or central systolic stress, is more appropriately
evaluated by determining central haemodynamic parameters [3].
The latter can be determined non-invasively during exercise using
applanation tonometry with pulse wave analysis [12,13]. This
technique permits determination of indices of central systolic
loading such as AIx and the augmented pressure (AP) and allows
calculation of the wasted LV pressure energy (ΔEW); a measure
described as proportional to the additional energy expended by
the LV to overcome early systolic wave reflection [14–16].
Adult patients with CF have a number of established
abnormal or altered responses to exercise challenge [17].
These include evidence of abnormal gas exchange and
pulmonary mechanics, a heightened plasma lactate and pro-
inflammatory cytokine and catabolic hormone response when
compared with healthy subjects [17,18]. In addition there is
evidence that the cardiac response to exercise in patients with CF
is blunted in comparison with healthy subjects [19,20]. This may
relate to altered LV mechanics from increased afterload [21].
We therefore undertook this study to investigate the effect of
light aerobic exercise on large artery haemodynamics in adult
patients with CF. We hypothesised that patients would have
evidence of increased central systolic loading during exercise in
comparison with age-matched controls. Given we previously
reported the greatest AIx in patients with CF related diabetes
(CFRD) [2], we separately examined the influence of CFRD on
exercise haemodynamic response.
2. Materials and methods
2.1. Subjects
Adult patients with confirmed CF were recruited together
with age, gender and body mass index (BMI) cohort matched
healthy non-smoking controls. All subjects provided written
informed consent and the study was approved by the Local
Research Ethics Committee (Guildford, UK). Assessments
occurred when patients were clinically stable as described
previously [2]. Healthy controls were either sedentary or only
recreationally active.
2.2. Study design
Subjects were requested to attend two hours following a light
breakfast. They abstained from exercise in the preceding 24 hand from caffeinated beverages and tobacco on the morning of
assessment. Where applicable, patients were requested to avoid
administering inhaled ß-2 agonists prior to attendance and
insulin within two hours of assessment.
Following calculation ofBMI (kg/m2);medication and smoking
histories were determined. Habitual physical activity levels were
determined by recall questionnaire relating to typical activity in the
preceding month and expressed inMETS/month; 1 MET = energy
expended at rest. [22]. Ten minutes of supine rest was then
followed by haemodynamic measurements (pre-exercise), venous
blood sampling and spirometry to determine forced expiratory
volume in one second (FEV1) and forced vital capacity (FVC).
Patients were classified as having CFRD based on UK guidelines
[23] and were on treatment with subcutaneous insulin.
2.3. Exercise protocol
Subjects were familiarized with the exercise equipment and
performed ten minutes of exercise on a stationary upright cycle
ergometer (Tunturi, Finland) in a quiet, temperature controlled
laboratory. Cadence was maintained at 50–60 rpm and
resistance was adjusted in order for each subject to attain 60%
of their age predicted maximum heart rate. Total work for the
exercise period was calculated by determining the area under
the curve for time vs. work and expressed in kilojoules (kJ).
Haemodynamic measures were recorded eight minutes into
exercise (exercise), on cessation (post-exercise) and ten minutes
post exercise (recovery). Cardiac measurements, peripheral
oxygen saturation (SpO2), Borg dyspnoea and ratings of
perceived exertion scores were taken pre and post exercise.
2.4. Haemodynamic measurements
Peripheral BP was recorded as the average of duplicate
brachial artery readings by mercury sphygmomanometry.
Central BP measurements, except those taken during exercise,
were recorded at rest in the supine position with applanation
tonometry of the radial artery using a hand-held microman-
ometer (Millar instruments, USA) [2]. Pulse wave analysis was
then used to generate a central arterial waveform (SphygmoCor,
AtCor Medical, Australia) and determine augmented pressure
(AP) and AIx; adjusted for a HR at 75 bpm (AIx75) [24]. Aortic
pulse wave velocity (PWV) was determined by sequentially
recording ECG gated carotid and femoral artery waveforms to
obtain pulse wave transit time and then dividing by the distance
between the two recording sites [24].
During exercise radial arterial waveforms were recorded
using servo-controlled applanation tonometry (CBM-7000,
Colin Corp., Japan) [11,25] and analyzed separately.
The ΔEW, the extra workload the LV must generate to
overcome early central pressure augmentation, was determined
fromΔEW=2.09⁎AP⁎ (ejection duration− time to reflection) [14].
2.5. Cardiac measurements
Cardiac output (CO) and stroke volume (SV)were determined
pre and post-exercise using haemodynamic bioreactance
Table 1
Data presented as mean (SD), unless ⁎ median (range) or † Geometric mean
(SD): Subject characteristics.
Characteristic Controls Patients
n=25 n=36 P-value
Age (years) 29.3 (5.8) 28.9 (9.0) 0.85
Gender (male:female) 18:7 25:11 0.83
Height (m) 1.76 (0.1) 1.72 (0.1) 0.08
Weight (kg) 72.0 (9.1) 68.2 (11.6) 0.18
BMI (kg/m2) 23.1 (1.8) 23.0 (3.1) 0.93
BSA (m2) 1.88 (0.15) 1.80 (0.20) 0.10
FEV1 (% predicted) 96.9 (7.9) 65.8 (21.3) b0.001
FVC (% predicted) 95.7 (10.0) 78.6 (19.2) b0.001
Physical activity (METS/month)⁎ 39 (31–50) 39 (31–66) 0.52
Biochemical measurement
IL-6 (pg/ml) † 0.6 (1.8) 2.4 (2.6) b0.001
GFR (ml/min) 111.4 (15.0) 107.2 (26.6) 0.48
Definition of abbreviations: BMI = body mass index, BSA = body surface area,
FEV1=forced expiratory volume in one second, FVC = forced vital capacity,
IL-6= interleukin 6 (in 24 control subjects), and GFR = estimated glomerular
filtration rate.
Table 2
Data presented as mean (SD). ⁎Pb0.05 difference from respective pre-exercise
value for group, †Pb0.05 difference from controls: Haemodynamic variables
pre and post exercise.
Parameter Pre-exercise Post-exercise
Controls Patients Controls Patients
HR (bpm) 62 (10) 72 (11)† 63 (9)* 75 (11)*†
PSBP (mmHg) 119 (10) 121 (12) 129 (13)* 131 (14)*
PDBP (mmHg) 76 (8) 77 (8) 77 (8) 79 (11)
PPP (mmHg) 43 (9) 44 (9) 52 (12)* 53 (14)*
MAP (mmHg) 89 (8) 92 (10) 93 (10)* 95 (10)*
AIx75 (%) −2.5 (11.6) 6.4 (11.7)† −3.2 (11.7) 5.9 (9.9)†
AP (mmHg) 1.6 (3.0) 2.9 (3.9)† 1.0 (3.3) 2.3 (3.9)†
ΔEW (dynes s/cm2) 619 (1104) 1058 (1484) 412 (1307)* 800 (1332)*
CSBP (mmHg) 104 (8) 107 (12) 110 (9)* 113 (12)*
CDBP (mmHg) 77 (8) 78 (8) 78 (8) 80 (10)
CPP (mmHg) 27 (5) 29 (7) 32 (7)* 33 (9)*
PPA (PPP:CPP) 1.56 (0.14) 1.56 (0.17) 1.59 (0.14)* 1.58 (0.16)*
APWV (m/s) 5.7 (0.8) 6.2 (1.6)† 5.8 (0.7)* 6.7 (1.6)†*
Definition of abbreviations: HR = heart rate, BP = blood pressure, PSBP =
peripheral systolic BP, PDBP = peripheral diastolic BP, PPP = peripheral pulse
pressure; MAP = peripheral mean arterial pressure, AIx75 = Heart rate adjusted
augmentation index, AP = augmented pressure, ΔEW = Left ventricular wasted
pressure energy, CSBP = central systolic BP, CDBP = central diastolic BP,
CPP = central pulse pressure, PPA = pulse pressure amplification, and APWV =
aortic pulse wave velocity.
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corrected for body surface area as cardiac index (CI) and stroke
volume index (SVI) respectively. Peripheral vascular resistance
(PVRI) was calculated as mean arterial pressure (MAP)/CI with
immediately post exercise PVR calculated using MAP acquired
during steady state exercise.
2.6. Laboratory analysis
Creatinine was measured (ADVIA 2400, Siemens medical
solutions) and estimated glomerular filtration rate (GFR) was
determined as described previously [2]. Serum interleukin-6
(IL-6) was determined by ELISA (Quantikine HS, R & D
systems, USA).
2.7. Data analysis
Data are reported as arithmetic mean (SD), unless otherwise
stated. Statistical analyses were made using the unpaired t-test,
Chi-squared test, Pearson's correlation coefficient and either
simple or repeated measures one way analysis of variance
(ANOVA) where appropriate. Post-hoc comparisons were
performed using Tukey's test. Analysis was performed using
SPSS 15 with a P valueb0.05 considered significant.
3. Results
3.1. Subject characteristics
Patients (n=36) and controls (n=25) were similar for gender
and mean age (Table 1). Similar proportions of patients (n=1)
and controls (n=1) were ex-smokers however one patient was a
current smoker.
Of the patients, 20 (56%) were homozygous for δF508
mutation, 28 (78%) were pancreatic insufficient and 11 (31%)
had CFRD. Current therapy for the patients (% of patients)
included long-term oral and inhaled antibiotics (97%), nebu-
lized DNAse (75%) and inhaled corticosteroid (67%). No
subjects were on anti-hypertensive or cholesterol lowering
medication.
Subjects completed the exercise period at the prescribed
intensity; mean (SD) 60.4 (1.3)% age-predicted HR, however
total work was lower in patients, 575 (264)kJ than controls, 740
(231)kJ (P=0.01). Median (range) perceived exertion of the
task was similar between patients, 11 (6–14), and controls, 11
(7–14); a score of 11 equating to a ‘light'intensity. Likewise,
post exercise Borg dyspnoea score was comparable between
patients, 1.5 (0–4), and controls, 2 (0.5–3) (PN0.05). In
patients, post exercise SpO2 was 97 (91–100)%.
3.2. Haemodynamic data
3.2.1. Pre-, post exercise and recovery measurements
No group for time interaction was observed for any
peripheral or central haemodynamic measure, however there
were between-group differences; HR (P=0.001), AIx75
(Pb0.001) and APWV (P=0.04) were greater in patients thancontrols in the presence of a similar MAP (Table 2). In contrast,
there was no difference in ΔEW (P=0.17) and AP (P=0.12).
In all subjects, ΔEW (P=0.02) (Fig. 1) was lower post
exercise whilst AP and AIx75 did not change from their
respective pre-exercise values (both PN0.05). Peripheral and
central systolic BP, PP, MAP and APWV were greater post
exercise (Table 2). By recovery, BP parameters had returned to
their respective pre-exercise values however APWV remained
greater and ΔEW lower than pre-exercise.
Fig. 1. Left ventricular wasted pressure energy (ΔEW) at pre-exercise, exercise,
post exercise and recovery. Values are mean ±SEM. ⁎Pb0.05 difference in
ΔEW from controls.
Fig. 2. Relationship between log10IL-6 and ΔEW in controls (○), non-CFRD
patients ( ) and CFRD patients (■). Symbols represent mean values with error
bars representing ±1 SEM. Definition of abbreviations: ΔEW=left ventricular
wasted pressure energy, IL-6 = interleukin-6, CFRD=CF related dia-
betes.⁎Pb0.05 difference in ΔEW from controls (ANOVA).
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Exercise was haemodynamically well tolerated in all subjects
with no evidence of arrhythmia nor exaggerated systolic BP rise;
peripheral systolic BP b200 mmHg for all subjects.
During exercise, despite a similar absolute HR and BP
profiles, patients had comparatively greater AP and ΔEW
(Fig. 1) with trend towards greater AIx (P=0.07) than control
subjects (Table 3).
In all subjects, exercise ΔEW was related to age (r=0.54,
Pb0.001), height (r=−0.43, Pb0.001), pre-exercise AIx75
(r=0.67, Pb0.001), FEV1 % predicted (r=−0.32, P=0.01) and
log10IL-6 (r=0.27, P=0.04) (Fig. 2).3.3. Cardiac output data
Complete cardiac output data was analyzed for 32 patients
and 18 controls (Table 4); three patient traces were excluded
due to an inadequate bioreactance waveform and data was not
available for one patient and seven controls.Table 3
Data presented as mean (SD): Haemodynamic variables during exercise.
Parameter Controls Patients P-value
HR (bpm) 114 (4) 113 (4) 0.30
PSBP (mmHg) 147 (16) 148 (19) 0.73
PDBP (mmHg) 80 (7) 83 (9) 0.19
PPP (mmHg) 66 (16) 65 (16) 0.79
MAP (mmHg) 100 (8) 104 (11) 0.09
AIx (%) −5.7 (11.2) −0.3 (10.9) 0.07
AP (mmHg) −2.2 (4.7) 0.4 (4.5) 0.03
ΔEW (dynes s/cm2) −576 (1400) 187 (1326) 0.03
CSBP (mmHg) 120 (10) 124 (15) 0.29
CDBP (mmHg) 83 (8) 87 (9) 0.15
CPP (mmHg) 37 (8) 38 (11) 0.90
PPA (PPP:CPP) 1.77 (0.11) 1.75 (0.14) 0.48
Definition of abbreviations: HR = heart rate, BP = blood pressure, PSBP =
peripheral systolic BP, PDBP = peripheral diastolic BP, PPP = peripheral pulse
pressure, MAP = peripheral mean arterial pressure, AIx = augmentation index,
AP = augmented pressure, ΔEW = Left ventricular wasted pressure energy
central pulse pressure, CSBP = central systolic BP, CDBP = central diastolic BP,
CPP = central pulse pressure, and PPA = pulse pressure amplification.In all subjects, SVI and CI were greater post-exercise whilst
PVRI was reduced from respective pre-exercise values (all
Pb0.001). Between groups, both SVI (Pb0.001) and CI
(P=0.03) were greater in controls than patients, whilst PVRI
was lower (P=0.01) (Table 4). Repeated measures ANOVA
revealed a significant group by time interaction for SVI;
indicating a more marked increase in post exercise SVI in the
control group (P=0.03).
In all subjects, pre-exercise CI was related to age (r=−0.30,
P=0.04) and BMI (r=−0.33, P=0.02) but not log10IL6
(P=0.58). In patients alone, the relationship between CI and
BMI persisted (r=−0.40, P=0.03) but there was no relationship
with age, pulmonary function or log10IL6 (all PN0.05).3.4. Influence of diabetic status
Patients with CFRD (n=11) were older than non-CFRD
patients; 34.5 (7.2) and 26.5 (8.8)years respectively (P=0.015).
They also had lower FEV1 % predicted, 47.5 (14.6)%, and
greater IL-6, 5.7 (3.9)pg/ml than non-CFRD subjects; 73.9
(18.7)% and 2.7 (2.8)pg/ml, respectively (all Pb0.05). There
was no difference in the median (range) physical activity levelsTable 4
Data presented as mean (SD). *Pb0.05 difference from pre-exercise, †Pb0.05
difference from controls at same time point: Cardiac variables pre and post
exercise.
Parameter Pre-exercise Post-exercise
Controls Patients Controls Patients
HR (bpm) 68 (10) 78 (12)† 82 (12)* 103 (9)*†
MAP (mmHg) 90 (7) 92 (11) 97 (8)* 104 (12)*
SVI (ml/m2) 58.0 (8.7) 45.0 (8.4)† 68.1 (17.3)* 47.9 (11.0)*†
CI (L/min/m2) 3.9 (0.3) 3.5 (0.6)† 5.5 (1.1)* 4.9 (1.2)*†
PVRI (mmHg/L/min/m2) 23.5 (3.0) 27.2 (6.0)† 18.3 (3.8)* 22.5 (7.1)*†
Definition of abbreviations: HR = heart rate, MAP = peripheral mean arterial
pressure, SVI = stoke volume index, CI = cardiac index, and PVRI = Peripheral
vascular resistance index. N.B. MAP at steady state exercise reported and used
in calculation of PVRI post exercise. Data available for 32 patients and 18
controls.
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66) and 39 (32–55) respectively (PN0.05).
During exercise, despite a similar absolute HR and
peripheral BP, patients with CFRD had greater MAP, AP and
ΔEW (Fig. 2) than control subjects (all Pb0.05, ANOVA).
Likewise there was a trend for exercise AIx to be greater in
CFRD than control subjects (P=0.07, ANOVA).
4. Discussion
Adults with mild to moderate severity CF have an abnormal
central haemodynamic response to exercise, as evidenced by a
comparatively greater ΔEW and AP, when compared with age,
BMI and gender matched controls. These vascular parameters
signify exaggerated central systolic loading and indicate
increased myocardial work in this setting of light physiological
stress. Such findings, apparent in young active patients have
functional relevance for cardiovascular health in the context of
repeated activities of daily living.
Exercise provides a valuable means of assessing the
cardiovascular system response to physiological stress and
evaluating its reserve [4]. Several studies have employed the
protocol used in this current study in order to evaluate the
influence of exercise on large arterial haemodynamics
[11,14,25,27]. In particular we [25] and others [14] have
previously reported evidence of amplified exercise-induced
central systolic stress in aged and hypercholesterolaemic non-
CF subjects using the same experimental procedures. The
current study demonstrates that the haemodynamic response to
exercise in patients with CF is in keeping with that reported in
the presence of a metabolic risk factor, such as hypercholester-
olaemia [25]. These findings thus advance our previous work,
which demonstrated abnormal haemodynamics at rest in
patients with CF [2], by providing evidence of additional
haemodynamic abnormalities during exercise.
Appropriate coupling between the cardiac and the arterial
systems is necessary to permit an efficient transfer of blood
from the LV to the periphery. In healthy individuals, exercise
induces marked changes in the morphology of the peripheral
pulse wave [5]. These changes appear to arise largely from
vasodilatation of the large muscular arteries possibly leading to
a reduction in pulse pressure wave reflection from the lower
body and hence attenuating late systolic central systolic
pressure augmentation. Overall these alterations act to optimize
ventricular–arterial coupling and reduce central systolic
loading; as indicated by a reduction in ΔEW. Thus, the
comparatively greater exercise ΔEW in patients with CF
suggests that the LV may be placed under additional stress
during exercise when compared with controls.
An important feature of this augmented exercise-induced
central systolic loading in patients with CF was that it was
apparent during light exercise. The exercise protocol employed
in this study was deliberately selected to approximate the
physical intensity of routine activities of daily living. The fact
that all subjects completed the full exercise period and indicated
a relatively low RPE and Borg dyspnoea score on completion
supports the light nature of the exercise.A previous study in patients with CF demonstrated that
cardiac atrioventricular filling patterns were altered, suggesting
disease related impairment of LV relaxation properties [21].
The mechanisms responsible for this were not fully elicited,
however, increased myocardial afterload was tabled as a
possible influential factor. In the non-CF population there are
now experimental [28] and emerging clinical [29] evidences to
link impaired LV relaxation and diastolic dysfunction with
increased afterload. Furthermore alterations in exercise hae-
modynamics have been shown to relate to myocardial
geometry, such as LV mass and relative wall thickness [7],
supporting the notion that chronic excessive myocardial
loading during activities of daily living may impact on cardiac
structure and function . On the basis of these data, our findings
of elevated central systolic stress could suggest that LV
relaxation properties in CF patients may be impaired due to
elevations in afterload arising from resting and light exercise
BP abnormalities. Further studies in the CF population are
needed to support this conjecture, however our finding of a
significant difference between patients and controls in absolute
SVI and its response to exercise highlights possible alterations
in cardiac function.
Exercise systolic loading was greatest in patients with CFRD
when compared with controls. This is consistent with the
findings in the general diabetic population who are known to
have an impaired peripheral vasodilator response to exercise
[30] and increased central systolic stress immediately post
exercise [7]. Indeed in healthy non-diabetic individuals, insulin
resistance is associated with an impaired brachial diastolic BP
response to exercise [31]. It should be noted however that we
did not find a difference between CFRD and non-CFRD
patients and as such further work is needed with greater diabetic
subject numbers to establish whether the presence of diabetes
per se influences exercise haemodynamics in the CF popula-
tion. Furthermore, it would be informative to perform a
comparison of exercise haemodynamic parameters between
patients with CFRD and a matched group of control subjects
with diabetes.
The factors that modulate central vascular parameters during
exercise are imprecisely defined [3] and a number of structural
and functional changes within the large arterial tree may explain
the differences between CF patients and controls. In keeping
with our previous work [2], we found a relationship between
resting AIx and indices of systemic inflammation, renal and
pulmonary function. In this current study we additionally found
both IL-6 andΔEW were greatest in CFRD, with an association,
albeit weak, between these two parameters in the whole study
population. Inflammatory markers are associated with increased
aortic stiffness and may act synergistically with the presence of
diabetes mellitus to promote alterations in large arterial
function; as seen in the general diabetic population [32].
Furthermore IL-6 has been shown to relate to right ventricular
diastolic dysfunction in the CF population [33], although its
relationship with LV function remains unknown.
A further factor which may act to influence arterial
haemodynamics during exercise in this patient population
relates to the interaction or interdependence between the
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demonstrated that increased respiratory loading can impact
upon intra-thoracic pressure to reduce peripheral vascular
compliance and arterial blood flow [34], although in the current
study we found no relationship between resting spirometric
measures of pulmonary function and exercise-induced central
systolic stress.5. Study limitations
In this study CO was determined using a non-invasive
technique of bioreactance monitoring. This technique is yet to
be validated in the CF population against a ‘gold standard’
method. We do not feel this limits our interpretation of the data
given the impedance principle underlying this technique has
previously been used and validated in the CF population [35]
and bioreactance offers advantages of not being influenced by
respiratory fluctuations or the precision of electrode placement
[26]. Furthermore, we selected to index cardiac parameters to
body surface area (e.g. as stroke volume index), however future
studies with larger subject numbers should consider the
importance of allometric scalling to allow a precise evaluation
of the impact of subject anthropometry on cardiac parameters
[36].
Exercise intensity was determined using age-predicted
maximum HR and it could be argued that a more precise
evaluation of relative exercise intensity could be obtained if
subjects had undergone prior formal maximal exercise testing or
lactate measurement. This choice of protocol was selected on
the basis of allowing individuals to exercise at an equivalent
relative HR; a key determinant of large artery haemodynamics.
The ‘light’ relative intensity of the exercise period is supported
by the fact that both patients and controls reported a similarly
low exercise RPE.6. Conclusion
Adult patients with CF have heightened central haemody-
namic stress during exercise, which has implications for
myocardial work and performance. This haemodynamic stress
during physical work is superimposed on abnormal resting
large artery haemodynamics and is relevant given it is
precipitated by exercise of a comparable intensity to activities
performed on a daily basis. Further studies are needed to
explore the extent of this contribution and long-term implica-
tions for both cardiovascular health and exercise capacity in the
adult CF population.Acknowledgments
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